Join Dr. Denisa Rensen for an informative session on the physics of PLASMA, as it relates to health and longevity.
In this session, she will focus on how plasma technology works in practice. The history, the present state of technological development, what is on the market now, and how Plasma Tech differs and stands out as the most precise and potent plasma delivery instrument in this day and age.
About the speaker:
DENISA RENSEN
Longevity & Regenerative Medicine | Founder & CEO, Plasma Inc. and ORA Future
Dr. Denisa Rensen is a longevity physician and systems designer advancing the frontier of regenerative biologics and biophysics. Her work focuses on extending the current model of longevity medicine toward interventions that operate at the level of fundamental physiological signaling and subcellular regulation.
As Founder and CEO of Plasma Inc. and the Plasma Institute, she develops plasma-based health technologies grounded in applied biophysics. These systems are designed to interact with biological processes at the level of cellular signaling, redox balance, and systemic regulation, with applications spanning human physiology and built environments.
She is also the Founder and CEO of ORA Future, a platform dedicated to the development of regenerative environments, hospitality concepts, and integrated health programs. Through ORA Future, her work translates clinical and biophysical innovation into spatial and lifestyle systems that support long-term human health and performance.
With over 25 years of clinical experience and fellowship training in Anti-Aging & Regenerative Medicine (A4M), Dr. Rensen’s work has included stem cells, exosomes, gene therapies, and advanced biologics. Her current focus builds on this foundation to advance biophysical approaches as a critical next layer in the evolution of regenerative medicine.
Dr. Rensen is an international speaker and a recurring contributor to the Unicorn Summit and other leading platforms in the future of healthcare. She is recognized for original, forward-looking contributions that integrate scientific, clinical, and systems-level thinking, and for helping define the next phase of longevity science.